Details for Patent: 9,375,410
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 9,375,410 protect, and when does it expire?
Patent 9,375,410 protects AMRIX and is included in one NDA.
This patent has one patent family member in one country.
Summary for Patent: 9,375,410
Title: | Modified release dosage forms of skeletal muscle relaxants |
Abstract: | A unit dosage form, such as a capsule or the like, for delivering a skeletal muscle relaxant, such as cyclobenzaprine hydrochloride, into the body in an extended or sustained release fashion comprising one or more populations of drug-containing particles (beads, pellets, granules, etc.) is disclosed. At least one bead population exhibits a pre-designed sustained release profile. Such a drug delivery system is designed for once-daily oral administration to maintain an adequate plasma concentration-time profile, thereby providing relief of muscle spasm associated with painful musculoskeletal conditions over a 24 hour period. |
Inventor(s): | Venkatesh; Gopi M. (Vandalia, OH), Clevenger; James M. (Vandalia, OH) |
Assignee: | ADARE PHARMACEUTICALS, INC. (Lawrenceville, NJ) |
Application Number: | 14/496,890 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,375,410 |
Patent Claim Types: see list of patent claims | Use; Formulation; Dosage form; Composition; |
Drugs Protected by US Patent 9,375,410
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Pharms Intl | AMRIX | cyclobenzaprine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021777-001 | Feb 1, 2007 | AB | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | RELIEF OF MUSCLE SPASM | See Plans and Pricing | |||
Teva Pharms Intl | AMRIX | cyclobenzaprine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021777-002 | Feb 1, 2007 | AB | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | RELIEF OF MUSCLE SPASM | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,375,410
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
World Intellectual Property Organization (WIPO) | 2005048996 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |